KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcosa (ACA) Gains from Investment Securities (2017 - 2025)

Arcosa's Gains from Investment Securities history spans 9 years, with the latest figure at $5.2 million for Q3 2025.

  • For Q3 2025, Gains from Investment Securities rose 326.09% year-over-year to $5.2 million; the TTM value through Sep 2025 reached $7.9 million, down 70.3%, while the annual FY2024 figure was $10.3 million, 63.48% down from the prior year.
  • Gains from Investment Securities for Q3 2025 was $5.2 million at Arcosa, up from -$7.2 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $24.7 million in Q4 2023 and bottomed at -$7.6 million in Q3 2023.
  • The 5-year median for Gains from Investment Securities is $700000.0 (2021), against an average of $2.2 million.
  • The largest YoY upside for Gains from Investment Securities was 10900.0% in 2022 against a maximum downside of 957.14% in 2022.
  • A 5-year view of Gains from Investment Securities shows it stood at $700000.0 in 2021, then plummeted by 957.14% to -$6.0 million in 2022, then soared by 511.67% to $24.7 million in 2023, then crashed by 65.99% to $8.4 million in 2024, then plummeted by 38.1% to $5.2 million in 2025.
  • Per Business Quant, the three most recent readings for ACA's Gains from Investment Securities are $5.2 million (Q3 2025), -$7.2 million (Q2 2025), and $1.5 million (Q1 2025).